RecruitingNot ApplicableNCT05841355
MADRE (Mammograms Available Due to Research and Education)
Sponsor
University of Illinois at Chicago
Enrollment
600 participants
Start Date
Mar 14, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and repeat Breast Cancer (BC) screening.
Eligibility
Sex: FEMALEMin Age: 40 YearsMax Age: 74 Years
Inclusion Criteria12
- Aim 1
- female biological sex
- identification as Latinas
- non-adherence to USPSTF guidelines (42-74 years old, no mammogram in past 2 years, no previous BC diagnosis)
- no previous history of health volunteerism
- not a network member enrolled in Aim 2.
- Aim 2.
- female biological sex
- eligibility to obtain BC screenings by USPSTF guidelines (i.e., 40-74 years old, no personal BC history)
- referral from Aim 1 participants
- no previous history of health volunteerism
- no participation in the RCT (not an Aim 1 participant, no Session #3 attendance).
Interventions
OTHEREducate
Education sessions
OTHEREmpower
Empowerment sessions
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05841355
Related Trials
Breast Density Impact on Mammographic Screening for Breast Cancer Diagnosis
NCT074154991 location
AI-Enhanced Imaging in Population Breast Cancer Screening
NCT074114431 location
B.Brilliant Revelation Comparision Study
NCT070677881 location
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
NCT069342396 locations
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
NCT0262085211 locations